Top Links

Articles Related to neoplasm

Superficial CD34-Positive Fibroblastic Tumor: First Case Report from Latin-America and Review of the Literature

Superficial CD34-positive fibroblastic tumor is an infrequent soft-tissue tumor characterized by a lesion located in the subcutaneous fascia without affecting the soft or deep muscle planes. Its incidence is unknown; therefore, it represents a diagnostic challenge for both the surgical oncologist and pathologist. Given its high risk of local recurrence, extensive surgical resection is the recommended treatment modality. This is the first report of this rare entity in Latin-America.
View complete article: PDF  |  Full-text

Gangliocytic Paraganglioma of the Appendix; A Rare Case Report and Review

Gangliocytic paraganglioma (GP) (nonchromaffin paraganglioma, paraganglioma) is a morphologically distinct tumor most commonly occurring in the second part of the duodenum in the proximity of ampulla of Vater. We herein, present a case report of appendiceal mass in a 16-year-old male who presented with recurrent right iliac fossa pain and steno sing cecal tumor on CT abdomen. He underwent right hemicolectomy and histopathological examination of appendix showed infiltration of appendiceal wall with gangliocytic paraganglioma. To our knowledge this is the first reported case of gangliocytic paraganglioma of appendix in our area.
View complete article: PDF  |  Full-text

Therapy-related Myeloid Neoplasms after Pediatric Solid Cancer in a Single Reference Cancer Center in Brazil

Pediatric cancer overall survival has increased due to improvements in treatment. However, long-term adverse effects are a challenge for this population. Secondary myeloid neoplasm (MN) is one of the complications of solid tumor treatment. Therapy-related myeloid neoplasms (t-MN), therapy-related acute myeloid leukemia (t-AML), and therapy-related myelodysplastic syndrome (t-MDS) are the most common events. The aim of this study was to report a large pediatric sample and the relevance of t-MN after pediatric solid tumor therapy. We conducted a retrospective study between 2000-2016 in a cohort of pediatric patients treated for solid tumors who developed a secondary MN by medical records review and analysis. Seven from 2178 pediatric patients who were previously treated for solid tumors, were diagnosed with t-MN in a reference cancer center in Brazil. The median age at primary tumor diagnosis was 12.8 years old. Osteosarcoma, atypical primitive neuroectodermal tumor (PNET), Ewing sarcoma, and retinoblastoma were the most frequent solid tumors associated with t-MN. Three patients had a story of familiar cancer, and one patient with osteosarcoma had Li-Fraumeni syndrome confirmed. The median latency period to secondary MN was ten months and the prevalence rate was 0.32%. Two patients developed t-MDS and five, t-AML. All these patients received cytotoxic agents’ high doses that may have been associated with t-MN development. t-MN initial control, as well as unfavorable cytogenetic abnormalities, may have contributed to the poor outcome. We described the rarity of t-MN related to previous solid tumor therapy in a large pediatric sample in a Brazilian Cancer Center and their poor prognosis.
View complete article: PDF  |  Full-text

Correlation of Hemostatic Parameters with Poly (ADP-ribose) Polymerase-1 (PARP-1) Polymorphisms, Mutations, Laboratory, and Clinical Characteristics in 114 Patients with Philadelphia-Negative Myeloproliferative Neoplasms

Patients with Philadelphia-negative myeloproliferative neoplasms (PN-MPN) are at a higher risk for venous thrombosis. Thromboelastometry may prove efficient to evaluate the patient’s thrombotic risk. In this study, based on data from 114 patients with PN-MPN from a single center in Greece, hemostatic profile was assessed with routine coagulation tests, Rotational Thromboelastometry (ROTEM® ), and Platelet Function Analyzer (PFA)-100 and correlated with clinical, laboratory, treatment characteristics, gene mutations and polymorphisms of poly (ADP-ribose) polymerase-1 (PARP-1)
View complete article: PDF  |  Full-text

Blastic Plasmacytoid Dendritic Cell Neoplasm Presenting as a Harbinger of Acute Myeloid Leukemia

A 51 year old female was referred to our dermatology clinic for a rapidly growing lump on head of 6 weeks duration. On examination we observed a 15 cm diameter erythematous crusted tumor on the forehead with significant bilateral cervical lymphadenopathy. An excision biopsy of the tumor revealed a malignant high grade diffuse undifferentiated infiltrating neoplasm involving the skin and subcutaneous tissue.
View complete article: PDF  |  Full-text

Clinical Complications, Incidental Neoplasms and Recurrence in Surgical Management of Multi Nodular Goiter

Thyroid tissue samples of 200 patients who underwent total thyroidectomy, near total thyroidectomy and subtotal thyroidectomy for surgical management of multinodular goiter were designed our study. The surgical procedures were performed between January 2016 and December 2018 in general surgery department MUST University. Preoperative ultrasound-guided fine needle aspiration cytology and the postoperative surgical specimens were delivered to pathology lab at MUST University 6th of October city, Giza. Patients with thyroid neoplasms, thyroiditis, toxic and recurrent goiter were excluded from the study. Personal and demographic data were collected and analyzed. Postoperative clinical complications and incidental neoplasms were evaluated. All the patients were followed up over 1 year for expected clinical complications, recurrence of goiter and appearance of neoplasms.
View complete article: PDF  |  Full-text

Recurrent Mucinous Ovarian Neoplasms: Rationale and Results of a New Treatment Plan in Four Patients

Recurrence of a mucinous ovarian neoplasm after resection is unusual but this does happen. If possible, a repeat surgical removal of recurrent disease is the treatment of choice. The results of a repeat intervention are poor. A review of our results of treatment of recurrent mucinous ovarian neoplasms was performed.
View complete article: PDF  |  Full-text

Pancreatic-Hydatid-Masquerading-as-Cystic-Neoplasm

Hydatid disease of the pancreas is a rare condition, with an incidence of less than 1%. Establishing diagnosis may be difficult because clinical and imaging findings are similar to other more commonly encountered cystic lesions of the pancreas. We present a case of isolated Hydatid cyst in the tail of pancreas which masquerading as the mucinous cystic neoplasm of the pancreas.
View complete article: PDF  |  Full-text

HCV in Lymphoid Neoplasms

HBV carrier cases
View complete article: PDF  |  Full-text

Inguinal Lymph Node Squamous Cell Carcinoma of Unknown Primary Site: A Case Report

Carcinoma of unknown primary site (CUP) is a heterogeneous group of malignancies associated with dismal prognosis. Although majority of the patients present with disseminated disease, some of them do present with disease limited to the lymph nodes.
View complete article: PDF  |  Full-text

Responses and Survival under Pegylated Interferon α2a Treatment for Patients with Post-MPN Acute Myeloid Leukemia and Acute Panmyelosis with Myelofibrosis

We report here for the first time the efficacy of pegylated interferon α2a (Peg-Ifn) as a therapy for patients with myelofibrosis and high blast counts. We treated four patients who were in an accelerated phase of myeloproliferative neoplasms or acute panmyelosis with myelofibrosis using only this drug.
View complete article: PDF  |  Full-text

Giant Mucinous Cystadenoma in Adolescent – A Rare Case Report

A 13 year old, premenarchal, previously healthy girl presented to the emergency department of our hospital with complaints of vomiting, constipation and abdominal pain for past one day. The patient also complained of slowly increasing abdominal distension and mild abdominal discomfort since past four months.
View complete article: PDF  |  Full-text

Prospective Evaluation of WHO and European Clinical, Molecular and Pathological (WHO-ECMP) Criteria for Myeloproliferative Neoplasms (MPN) of Various Molecular Etiology: Characteristics of JAK2V617F, MPL515 and CALR Mutated MPN

The WHO defined JAK2V617F mutated myeloproliferative neoplasms (MPN) consist of normocellular essential thrombocythemia (ET), ET with features of early PV (prodromal PV), ET with hypercelular megakaryocytic granulocytic myeloproliferation (ET.MGM), and various stages of polycythemia vera (PV) when the WHO and European Clinical and Pathological (WHO-ECMP) criteria are applied.
View complete article: PDF  |  Full-text

The Emergence of Multiple Myeloma in a Patient with Essential Thrombocythemia: A Case Report

Multiple myeloma is a neoplastic disease characterized by neoplastic proliferation of plasma cells and monoclonal protein expression and related tissue damage.In the presence of overt clinical signs, the disease can easily be diagnosed, however in order to diagnose atypical cases, further investigation is needed with high clinical suspicion.
View complete article: PDF  |  Full-text

An Interesting Coexistence of a Classical-Nodular and an Adenoid-Ulcerous Basal Cell Carcinoma in the Same Anatomic Location

Basal cell carcinoma is the most frequent malignant tumor of the skin, and the most common carcinoma found in some countries. The main clinical subtypes of BCC are nodular, superficial, pigmented and morpheaform. The majority of the lesions appear on the head and neck, with a particular predilection on the upper central part of the face.
View complete article: PDF  |  Full-text


Editorial Board Members Related to neoplasm

Dimitrios Kanakis

Associate Professor
Department of Pathology
University of Nicosia Medical School
Cyprus

Julie Teruya-Feldstein

Director
Hematopathology
Immunohistochemistry Laboratory
United States

MING-JEN CHEN

Assistant Professor
Division of Gastroenterology
Department of Internal Medicine
Mackay Medical College
Taiwan

Alfio Ferlito

Professor
Department of Otolaryngology
University of Udine School of Medicine
Italy

Jason X. Cheng

Assistant Professor
Department of Pathology, Hematopathology
University of Chicago
United states

Norhafiza Mat Lazim

Department of Otorhinolaryngology-Head & Neck Surgeon
School of Medical Sciences
Universiti Sains
Malaysia

Pankaj Srivastava

VATS Surgeon
Om Surgical Center & Maternity Home
Varanasi
India

Alfio Ferlito

Professor
Department of Surgical Sciences
University of Udine
Italy.

Francesco Passamonti

Professor of Hematology
University Hospital Ospedale di Circolo
Fondazione Macchi, Varese
Italy
Submit Manuscript